Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Journal of Medicinal Chemistry|December 17, 2008
Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behaviorStefania Butini, Sandra Gemma, Giuseppe Campiani, et al.ACS Chemical Neuroscience|April 23, 2021
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic AgentsAlessandro Grillo, Filomena Fezza, Giulia Chemi, et al.Journal of Medicinal Chemistry|December 31, 2008
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarialsSandra Gemma, Giuseppe Campiani, Stefania Butini, et al.ACS Pharmacology & Translational Science|July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Sara Rossi, Valentina Giudice, et al.European Journal of Medicinal Chemistry|May 7, 2016
Development of novel cyclic peptides as pro-apoptotic agentsMargherita Brindisi, Samuele Maramai, Simone Brogi, et al.Journal of Medicinal Chemistry|January 5, 2026
Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In VivoGabriele Carullo, Federica Falbo, Valeria Tudino, et al.Journal of Medicinal Chemistry|December 30, 2003
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agentsGiuseppe Campiani, Stefania Butini, Caterina Fattorusso, et al.Journal of Medicinal Chemistry|November 14, 2012
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agentsSandra Gemma, Caterina Camodeca, Margherita Brindisi, et al.Bioorganic Chemistry|October 18, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cellsIlaria Cursaro, Luca Frattaruolo, Laura Scalvini, et al.Journal of Medicinal Chemistry|July 13, 2012
Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profilingSandra Gemma, Caterina Camodeca, Salvatore Sanna Coccone, et al.Pageof 15